CervoMed CRVO
NASDAQ CRVO
$2.62 +0.06 (+2.34%)
At close: Aug 21, 2026 · 4:00 PM EDT

CervoMed (CRVO) Short-Term Debt issuances (2010 - 2011)

CervoMed (CRVO) posted Short-Term Debt issuances of -$6.0 for Q4 2011, down 100.01% sequentially from $62796.0 in Q4 2010, and down 100.01% YoY from $62796.0 in Q4 2010.

CervoMed (CRVO) Short-Term Debt issuances (2010 - 2011) Analysis & Trends

CervoMed has reported Short-Term Debt issuances for 2 years, with the latest figure at -$6.0 in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 CervoMed 26.64 Mn 26.64 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2011 -6.00
Dec 31, 2011 -6.00
Dec 31, 2010 62,796.00
Dec 31, 2010 62,796.00